WebSite > Sichuan Qingmu Pharmaceutical Co., Ltd.
Sichuan Qingmu Pharmaceutical Co., Ltd.
- Company Name Sichuan Qingmu Pharmaceutical Co., Ltd.
- Tel 028-87827187
- Email sales@eastonpharma.cn
- WebSite www.qingmupharm.com/
- CB Index 60
- Sichuan Qingmu Pharmaceutical Co., Ltd. is a wholly owned subsidiary company of Chengdu Easton Biopharmaceuticals Co., Ltd. (Stock Code: 688513), which is mainly engaged in research, production and marketing of APIs, CMO/CDMO business of APIs & advanced intermediates are also welcome. Qingmu was established in 2011, with more than 30% of staffs in R&D unit, 16 products are commercialized till now. Our facility is fully designed and operated as per EU/US/Japan GMP and EHS requirements, QC lab is equipped with HPLC, GC and ICP-MS, GC-MS, Malvern particle sizer, XRD, TGA, DSC, etc., which leads to GMP certificates for 10 APIs, 3 J-MFs, 1 USDMF, 1 USVMF and 1 CEP, and more certificates are on the way. Advantages of R&D 1) Process design based on the concept of QbD & Green chemistry to strengthen in-process quality control and EHS compliance. 2) Comprehensive quality research system which can meet the registration requirements in both Chinese and main regulatory markets (Japan, USA, EU, etc.). 3) Experienced in patent challenging on polymorphism form and synthesis process of APIs. Advantages of facility 1) 16 production lines and 4 independent clean areas for regular APIs with reaction volume 50~5000L. 2) OEB-4 workshop equipped with 4 production lines and 1 clean area, reaction volume 20~1000L. 3) 3 special reaction production lines, equipped with devices which suitable for 6 dangerous processes: hydrogenation, oxidation, chlorination, sulfonation, diazotization, and alkylation. 4) Qualified to produce Schedule II Controlled Substance APIs, and 3 products have been filed for registration. 5) Cytotoxic oncology APIs workshop is under construction. 6) Reaction temperature: -100β~250β; Pressure range: 0~8MPa. CDMO successful cases: 1) One National Class 1 New drugs (NCE) had been approved in 2020, realizing commercial supply of API. 2) Process validation of one patent challenge project has been successfully completed, and ASMF to be filed in EU
Sichuan Qingmu Pharmaceutical Co., Ltd. Product List
- Product Name Fasudil Hydrochloride
- MF C14H18ClN3O2S
- CAS 105628-07-7
- Product Name Apalutamide
- MF C21H15F4N5O2S
- CAS 956104-40-8
- Product Name Dacomitinib
- MF C24H25ClFN5O2
- CAS 1110813-31-4
- Product Name Olanzapine
- MF C17H20N4S
- CAS 132539-06-1
- Product Name Etoricoxib
- MF C18H15ClN2O2S
- CAS 202409-33-4
- Product Name Neostigmine Methylsulfate
- MF C12H19N2O2.CH3O4S
- CAS 51-60-5
- Product Name Parecoxib sodium
- MF C19H19N2NaO4S
- CAS 198470-85-8
- Product Name Bisoprolol Fumarate
- MF C22H35NO8
- CAS 104344-23-2
- Product Name Dabigatran Etexilate Mesylate
- MF C35H45N7O8S
- CAS 872728-81-9
- Product Name Aprepitant
- MF C23H21F7N4O3
- CAS 170729-80-3
- Product Name Nilotinib HCL
- MF C28H25ClF3N7O2
- CAS 923288-90-8
- Product Name Silodosin
- MF C25H32F3N3O4
- CAS 160970-54-7
- Product Name Maropitant Citrate
- MF C38H48N2O8
- CAS 359875-09-5
- Product Name Firocoxib
- MF C17H20O5S
- CAS 189954-96-9
- Product Name (1R,2S)-2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl]-methyl acetate
- MF C13H15FO3
- CAS 1369768-29-5
- Product Name 2,4-Dimethyl-5-pyrimidinol
- MF C6H8N2O
- CAS 412003-95-3
- Product Name (S)-3-(4-Bromophenyl)piperidine
- MF C11H14BrN
- CAS 1335523-82-4
- Product Name 2-hydroxy-2-methyl-1-(4-(methylsulfonyl)-phenyl)propan-1-one
- MF C11H14O4S
- CAS 180048-73-1
- Product Name 5-Acetylthiophene-2-carboxylic acid
- MF C7H6O3S
- CAS 4066-41-5
- Product Name (S)-tert-butyl 3-(4-aMinophenyl)piperidine-1-carboxylate
- MF C16H24N2O2
- CAS 1171197-20-8
- Product Name 6-HYDROXY-2-METHYLBENZOFURAN-3-CARBOXYLIC ACID
- MF C10H8O4
- CAS 854515-52-9
- Product Name 4-Aminobenzamidine dihydrochloride
- MF C7H11Cl2N3
- CAS 2498-50-2
- Product Name 2-Butenoic acid, 3-amino-, 2-cyanoethyl ester
- MF C7H10N2O2
- CAS 43107-08-0
- Product Name 1,2-Cyclopropanedimethanol, 1-(3-fluorophenyl)-, 2-acetate 1-(4-methylbenzenesulfonate), (1S,2R)-
- MF C20H21FO5S
- CAS 1450904-92-3
- Product Name 6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide
- MF C11H11NO3
- CAS 638217-08-0
- Product Name 1-Aminocyclobutanecarboxylic acid
- MF C5H9NO2
- CAS 22264-50-2
- Product Name 5-AMINO-3-(TRIFLUOROMETHYL)PICOLINONITRILE
- MF C7H4F3N3
- CAS 573762-62-6
- Product Name 5-isothiocyanato-3-(trifluoromethyl)picolinonitrile
- MF C8H2F3N3S
- CAS 951753-87-0
- Product Name (1S,2R)-2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-1-(3-fluorophenyl)cyclopropanemethanol
- MF C27H31FO2Si
- CAS 1369767-21-4
- Product Name (1S,5R)-1-(3-Fluorophenyl)-3-oxabicyclo[3.1.0]hexan-2-one
- MF C11H9FO2
- CAS 528587-70-4
- Product Name (1S,2R)-1-(3-Fluorophenyl)-1,2-cyclopropanedimethanol
- MF C11H13FO2
- CAS 1369767-20-3
- Product Name mirogabalin Besilate
- MF C18H25NO5S
- CAS 1138245-21-2
- Product Name 6-methoxy-2-methylbenzofuran-3-carboxylic acid
- MF C11H10O4
- CAS 103986-33-0
- Product Name (1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one
- MF C9H12O
- CAS 1235479-61-4
- Product Name 1-cyclopropyl-7-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- MF C14H12FNO4
- CAS 221221-16-5
- Product Name 1-Azabicyclo[2.2.2]octan-3-one, 2-(diphenylmethyl)-, (2S)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (9CI)
- MF C24H27NO7
- CAS 683206-54-4
- Product Name Carbamic acid, N-[(3S,5S)-5-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester
- MF C11H22N2O2
- CAS 951163-61-4
- Product Name Niraparib tosylate monohydrate; Niraparib tosylate
- MF C26H28N4O4S
- CAS 1613220-15-7
- Product Name LURBINECTEDIN
- MF C41H44N4O10S
- CAS 497871-47-3
- Product Name (S)-3-(4-bromophenyl)piperidine hydrochloride
- MF C11H15BrClN
- CAS 2141967-71-5
- Product Name alpha-[(cyclopropylamino)methylene]-2,4-difluoro-3-methoxy-beta-oxo-benzenepropanoic acid ethyl ester
- MF C16H17F2NO4
- CAS 221221-13-2
- Product Name Rotigotine
- MF C19H25NOS
- CAS 99755-59-6
- Product Name Sugammadex sodium
- MF C72H104Na8O48S8
- CAS 343306-79-6
- Product Name Relugolix
- MF C29H27F2N7O5S
- CAS 737789-87-6
- Product Name Ruxolitinib Phosphate
- MF C17H21N6O4P
- CAS 1092939-17-7
- Product Name lenvatinib Mesylate
- MF C22H23ClN4O7S
- CAS 857890-39-2
- Product Name Brexpiprazole
- MF C25H27N3O2S
- CAS 913611-97-9
- Product Name axitinib
- MF C22H18N4OS
- CAS 319460-85-0
- Product Name Maropitant base
- MF C32H40N2O
- CAS 147116-67-4
- Product Name Afoxolaner
- MF C26H17ClF9N3O3
- CAS 1093861-60-9
- Product Name Ubenimex
- MF C16H24N2O4
- CAS 58970-76-6
- Product Name Ticagrelor
- MF C23H28F2N6O4S
- CAS 274693-27-5
- Product Name Ibrutinib
- MF C25H24N6O2
- CAS 936563-96-1
- Product Name Sodium Fusidate
- MF C31H49NaO6
- CAS 751-94-0
- Product Name Oclacitinib Maleate
- MF C19H27N5O6S
- CAS 1208319-27-0
- Product Name Abemaciclib
- MF C27H32F2N8
- CAS 1231929-97-7
- Product Name OMadacycline (tosylate)
- MF C36H48N4O10S
- CAS 1075240-43-5
- Product Name Fruquintinib
- MF C21H19N3O5
- CAS 1194506-26-7
- Product Name Lotilaner
- MF C20H14Cl3F6N3O3S
- CAS 1369852-71-0
- Product Name Robenacoxib
- MF C16H13F4NO2
- CAS 220991-32-2
- Product Name Sarolaner
- MF C23H18Cl2F4N2O5S
- CAS 1398609-39-6
- Product Name Ixazomib Citrate
- MF C20H23BCl2N2O9
- CAS 1239908-20-3
- Product Name Nemonoxacin Malate
- MF C20H25N3O4.C4H6O5
- CAS 951163-60-3
- Product Name Darolutamide
- MF C19H19ClN6O2
- CAS 1297538-32-9
- Product Name Ponatinib Hydrochloride; Ponatinib HCL
- MF C29H28ClF3N6O
- CAS 1114544-31-8
- Product Name Rotigotine Hydrochloride
- MF C19H26ClNOS
- CAS 125572-93-2
- Product Name Mirogabalin base
- MF C12H19NO2
- CAS 1138245-13-2
- Product Name SN-38
- MF C22H20N2O5
- CAS 86639-52-3